Market Cap: $511.8M
Market Cap: $511.8M
Shifting Dynamics in the Medical Device Sector: Angiodynamics' Position Amidst Market Sentiment Amidst a landscape of cautious investor sentiment reflected in the CNN Money Fear and Greed index, Angio…
Orthofix Medical: A Watchful Eye on Revenue Growth and Strategic Innovations Orthofix Medical stands at a pivotal moment as it approaches its quarterly earnings announcement on November 4, 2025. The u…
Orthofix Medical: Strategic Investments Pave the Way for Future Growth Orthofix Medical is gearing up for a pivotal earnings announcement on November 4, 2025, which is expected to shed light on its op…
AngioDynamics' Strong Performance Fuels Confidence in Growth Strategies AngioDynamics, Inc., a key player in the medical technology sector, reports exceptional first-quarter results that surpass marke…
Angiodynamics Focuses on Innovation Amid Industry Challenges Angiodynamics, a leader in the medical device industry, continues to prioritize innovation in its product offerings as it navigates a lands…
AngioDynamics Poised for Growth Ahead of Quarterly Earnings Announcement AngioDynamics is gearing up for its quarterly earnings report scheduled for October 2, 2025. As the company prepares to share i…
AngioDynamics Prepares for Strategic Earnings Announcement Amidst Product Expansion AngioDynamics (NASDAQ: ANGO) gears up for its quarterly earnings announcement on October 2, 2025, with significant a…
AngioDynamics Reports Impressive Fourth Quarter Results Amid Challenges in Healthcare Sector AngioDynamics Inc. (NASDAQ: ANGO) reveals its financial results for the fourth quarter of 2025, reporting a…
AngioDynamics Gears Up for Earnings Report Amidst Positive Market Trends AngioDynamics, a leader in innovative medical devices and therapies, is set to release its quarterly earnings report on July 15…
AngioDynamics Poised for Growth Amid Evolving Healthcare Landscape AngioDynamics, a key player in the medical device industry, is gearing up for the release of its quarterly earnings report on July 15…
AngioDynamics Gears Up for Quarterly Earnings Amid Positive Sector Trends AngioDynamics, a prominent player in the medical device industry, prepares to release its quarterly earnings report on July 15…
AngioDynamics Embarks on Groundbreaking AMBITION BTK Trial to Combat Critical Limb Ischemia AngioDynamics, Inc., a leading medical technology company dedicated to improving vascular health, announces…
AngioDynamics Showcases Commitment to Vascular Health and Cancer Treatment at Upcoming Healthcare Conference AngioDynamics, Inc., a leading player in the medical technology sector, prepares to partici…
AngioDynamics Secures FDA Clearance for Innovative Prostate Treatment AngioDynamics, Inc., a leader in medical technology dedicated to improving vascular health and cancer therapies, achieves a signif…